Noveris Announces Resignation Of CEO

Vancouver, British Columbia, March 10, 2026 – TheNewswire — Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today that Joshua Bartch has resigned as director, president and chief executive officer of the Company. The Company has appointed Jason Birmingham, who was previously appointed chief strategy officer on February 2, 2026, to assume all three positions formerly held by Mr. Bartch.